Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Cash from Investing Activities (2016 - 2025)

Aethlon Medical filings provide 14 years of Cash from Investing Activities readings, the most recent being $2192.0 for Q1 2025.

  • On a quarterly basis, Cash from Investing Activities rose 144.67% to $2192.0 in Q1 2025 year-over-year; TTM through Dec 2024 was -$7099.0, a 97.24% increase, with the full-year FY2024 number at -$250867.0, up 73.4% from a year prior.
  • Cash from Investing Activities hit $2192.0 in Q1 2025 for Aethlon Medical, up from -$2192.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2192.0 in Q1 2025 to a low of -$739165.0 in Q3 2022.
  • Median Cash from Investing Activities over the past 5 years was -$38374.0 (2021), compared with a mean of -$103228.0.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 3944.91% in 2022 and later surged 144.67% in 2025.
  • Aethlon Medical's Cash from Investing Activities stood at -$57934.0 in 2021, then tumbled by 161.48% to -$151486.0 in 2022, then skyrocketed by 94.19% to -$8807.0 in 2023, then soared by 75.11% to -$2192.0 in 2024, then skyrocketed by 200.0% to $2192.0 in 2025.
  • The last three reported values for Cash from Investing Activities were $2192.0 (Q1 2025), -$2192.0 (Q4 2024), and -$4907.0 (Q1 2024) per Business Quant data.